COVID-19 and cardiovascular disease

Guijarro, Carlos

doi:10.1016/j.artere.2020.11.005

Cited by 1 publication

(2 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The DIC pathophysiology in SARS-CoV-2 includes EC, leukocyte, and platelet activation, fibrin deposition, resulting in diffuse inflammation and coagulopathy. 66,[78][79][80] It was proposed that the COVID-19 microthrombus phenotype aligns more closely with complementmediated thrombotic microangiopathy that is supported by the presence of anemia, elevated LDH, and renal dysfunction in severe SARS-CoV-2 cases. Microvascular dysfunction in SARS-CoV-2 via ACE2 receptor interactions and mannan-binding lectin serine protease (MASP) MASP-2 in the lectin pathway of complement activation is done.…”

Section: Thrombotic Complicationsmentioning

confidence: 99%

See 1 more Smart Citation

COVID-19’s immuno-pathology and cardiovascular diseases

Nasab

Aghajani

Makoei

et al. 2023

Journal of Investigative Medicine

View full text Add to dashboard Cite

The pandemic of COVID-19 in worldwide causes recent millions of morbidity and mortality in all countries and is the most important challenge in the world in recent years. Coronavirus is a single-stranded RNA virus and infection with COVID-19 leads to acute respiratory distress syndrome, lung inflammation, cytokine storm, and death. The other complications include endothelial dysfunction, activation of coagulation, thromboembolic events, and vascular disease. Cardiovascular complications such as myocardial and stroke ischemia, pulmonary thromboembolism, systemic arterial, and deep vein thrombosis were reported. In this review, we presented immuno-pathological mechanisms and the effects of COVID-19 on the cardiovascular system, heart, vessels, coagulation system, and molecular glance of immuno-inflammation to the COVID-19’s pathology on the cardiovascular system.

show abstract

Section: Thrombotic Complicationsmentioning

confidence: 99%

“…The DIC pathophysiology in SARS-CoV-2 includes EC, leukocyte, and platelet activation, fibrin deposition, resulting in diffuse inflammation and coagulopathy. 66 , 78 – 80…”

Section: Introductionmentioning

confidence: 99%